|
 |
| DRUG WATCH |
|
|
|
| Year : 2019 | Volume
: 51
| Issue : 5 | Page : 346-349 |
| |
Case report on premature hair graying treated with Melitane 5% and oral hair supplements
Jagdish J Sakhiya, Dhruv J Sakhiya, Mehul R Patel, Feral R Daruwala
Department of Dermatology, Sakhiya Skin Clinic, Surat, BJ Medical College, New Civil Hospital, Ahmedabad, Gujarat, India
| Date of Submission | 14-Mar-2019 |
| Date of Decision | 11-Oct-2019 |
| Date of Acceptance | 10-Nov-2019 |
| Date of Web Publication | 26-Nov-2019 |
Correspondence Address:
Dr. Jagdish J Sakhiya
Sakhiya Skin Clinic, 2nd Floor, Ayush Doctor House, Station-Lal Darwaja Road, Surat - 395 003, Gujarat
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_166_19
With chronological aging, hair turns gray. Untimely premature hair graying (PHG) may tremendously influence on cosmesis, self-credibility, and social life of the affected individuals. Consequently, early treatment is required to improve cosmetic appearance. To the best of our knowledge, until today, only one case of PHG is reported in the literature, and it occurred due to iron deficiency and successfully treated with ferrous sulfate. Herein, we delineate a case of PHG in a 14-year-old female treated with the topical formulation of Melitane 5% and oral hair supplements which resulted in boosting improvement in hair color.
Keywords: Melitane, oral hair supplements, premature hair graying
How to cite this article:
Sakhiya JJ, Sakhiya DJ, Patel MR, Daruwala FR. Case report on premature hair graying treated with Melitane 5% and oral hair supplements. Indian J Pharmacol 2019;51:346-9 |
How to cite this URL:
Sakhiya JJ, Sakhiya DJ, Patel MR, Daruwala FR. Case report on premature hair graying treated with Melitane 5% and oral hair supplements. Indian J Pharmacol [serial online] 2019 [cited 2023 Oct 1];51:346-9. Available from: https://www.ijp-online.com/text.asp?2019/51/5/346/271594 |
| » Introduction | |  |
Graying of hair is defined as a physiological process of chronological aging without any gender or race bias. Biologically, the gradual destruction of melanin pigment-generating cells called “melanocytes” seems to be correlated with gray hair processing. Premature hair graying (PHG) also called premature canities or achromotrichia described by the onset of the hair graying before the age of 20 in Whites,25 in Asians and 30 in Africans. However, till today, the exact etiology of PHG is still unclear and much speculative; therefore, it is a usual cause of referral to dermatologists. PHG perhaps appears alone as an autosomal prevailing characteristic or once in a while connected with different autoimmune disorders involving hypothyroidism, pernicious anemia, and premature aging syndromes such as Werner's syndrome. Furthermore, in the pathogenesis of PHG, the role of environmental determinants such as climate, ultraviolet radiation, smoking habit, some medications, trace elements, and nutritional scarcities have been postulated, too. It has also been hypothesized that trace element insufficiencies involving iron, copper, Vitamin B12, Vitamin D3, and calcium have been proved to influence hair growth and pigmentation and therefore may be also associated with PHG. PHG is frequently seen as an indication of old age and loss of health and vigor. As a result, affected individuals are often subjected to social stigma, discrimination, and difficulties in marriage; hence, its early treatment is crucial from a cosmetic point of view. In spite of the advance molecular exploration being done to comprehend the pathogenesis of graying, treatment alternative still stays away from satisfactory and the efficient remedy is not procurable.[1] To the best of our knowledge, until today, only one case of PHG is reported in the literature, and it occurred due to iron deficiency and successfully treated with ferrous sulfate.[2] Herein, we report a case of PHG treated with topical formulation of Melitane 5% and oral hair supplements which resulted in promising improvement in hair color.
| » Case Report | | |
A 14-year-old female presented with a history of graying of hair on her scalp since childhood. On physical examination, a higher portion of gray hair mingle with natural black-coloured hair was found on the scalp. Graying of hair started at the frontal and parietal region, and gradually, it extended to the temporal and occipital region of the scalp [Figure 1]. Her family history of PHG was noncontributory. Besides, a history of autoimmune diseases such as alopecia areata, vitiligo, autoimmune thyroid disorder, pernicious anemia, and any associated rare premature syndrome demonstrating PHG was absent. Routine laboratory parameters were within standard limits, and notably, serum calcium, serum iron, serum ferritin, serum zinc, serum copper, Vitamin C, Vitamin D3, Vitamin B12, and other thyroid function tests were within the normal range. On the basis of all laboratory findings, the exact etiology of PHG could not be found; the author's thought to be genetic etiology was the mainstay for the occurrence of PHG in our case. The topical formulation of 5% Melitane aqua gel was prescribed for once daily on the scalp. The patient was instructed to use it. Firstly, wash the scalp with a mild shampoo and then pour the gel directly onto the affected part of the scalp with two fingers, around 2 g daily, and massage the scalp to ensure that the gel is evenly spread. Then allowed the gel to absorb within 30 min, finally no rinsing was required. Then, allowed the gel to absorb within 30 min, finally, no rinsing was required. Tablets of oral hair supplements containing a combination of biotin, calcium pantothenate, element copper, element manganese, element selenium, element zinc, folic acid, and N-acetyl cysteine was also prescribed for 24 months. After 6 months, the patient was showing the improvement. At about 24-month duration, treatment was stopped at that time the patient achieved >95% conversion of gray hair to black hair [Figure 2]. The patient did not develop any reoccurrence after 6 months of stopping treatment. | Figure 1: A lot of gray hairs admixed with normal colored hairs on the scalp
Click here to view |
 | Figure 2: After 24 months of Melitane and oral hair supplement treatment, hair color recovered perfectly normal black color without graying hairs
Click here to view |
| » Discussion | | |
Fatemi Naieni et al.[1] researched the association between iron, zinc, copper serum concentrations, and premature canities, and the findings revealed that a low serum copper concentration might play a prominent role in PHG in our community. Apart from these, low iron concentration is further a crucial factor for PHG, and zinc level did not seem to be an effect on PHG. Bhat et al.[3] stated that the level of serum calcium, serum ferritin, and Vitamin D3 was decreased in PHG patients and might be playing a role in PHG in our society. As per the published report by Sonthalia et al.,[4] heredity, Vitamin B12 insufficiency, and hypothyroidism are a crucial factor associated with PHG. In the present case, we have taken into account all these parameters to recognize the exact pathogenesis for PHG, significant results argued the role of these parameters in this case, and the author believed that genetic etiology might be a crucial factor in the presented case.
Goodier and Hordinsky[5] hypothesized that genetic elements have a major effect on the hair follicle stem cells and melanocytes. Telomere shortening, reduction in cell counts, and sparse transcription factors have all been involved in the aging process. In turn, these molecular remodelings result in structural alterations of the hair fiber, reduced melanin generation, and expanding of the telogen phase of the hair cycle. At the molecular level, various genes and signaling pathways that influence hair pigmentation are being studied. Han et al.[6] postulated receptors for bone morphogenetic protein and activins that are Bmpr2 and Acvr2a are known to influence hair pigmentation and their reduced activity can cause early graying in preclinical studies. Schouwey et al.[7] deliberated that Notch 1 and Notch 2 signaling pathways play a predominant role in the upkeep of hair pigmentation. Hachiya et al.[8] contemplated that stem cell factor (SCF) is a cytokine involved in many physiological processes such as hematopoiesis. Recently, SCF and its receptor (kit) are determined to have a role in melanogenesis during anagen phase.
However, various treatment strategies are available, and only a few treatment options are satisfactory; hence, the treatment of PHG is still challenging. The treatment for PHG should be directed to address the cause. Vitamin B12 deficiency and hypothyroidism are reversed with vitamin and hormone replacement, respectively. Iron deficiency is reversed by ferrous sulfate which was reported in a case report by Choi et al. Although various vitamins and minerals such as biotin, calcium pantothenate, zinc, copper, and selenium are being prescribed, the results have not been promising. Green tea extract, selenium, copper, phytoestrogens, and melatonin are being studied as attractive topical antiaging compounds. Various topical preparations containing phytic acid, amino acids, peptides, acetyl hexapeptide-1, Melitane, Capixyl, pea proteins, etc., are already available in the market. Currently, for therapeutic and cosmetic alteration of hair, topical liposome-targeting melanins, genes, and proteins selective to hair follicles are the modern era of research.[1] Recently, the research is still going on to find ideal treatment, yet no definite treatment option is concluded. Here, in our case, we treat the patient with a topical formulation of Melitane 5% and oral hair supplements, and the patient felt a satisfactory improvement in hair color. Further research should be done with more number of patients to conclude more beneficial justification. Melitane™ is a newer molecule for PHG and originally agonist of α-melanocyte-stimulating hormone (α-MSH) biomimetic peptide. It acts through melanocortin 1 receptor; the process of melanogenesis (the production and release of melanin by melanocytes in skin and hair) is stimulated by α-MSH.[9] Besides, it has a defensive action on DNA damage provoked by ultraviolet A or B radiations and lessens the number of sunburn cells attesting a DNA repair action, for maximal antiaging benefits. Melitane™ also restricts the expression of biochemical inflammation mediators and contributes a significant protection against UV-induced erythema, reducing skin redness as utilized for a healthy glow and skin protection. The use of 0.5%–5% topical Melitane™ for 4–6 months is being promoted to stimulate hair pigmentation and reverse hair graying and mainly recommended for premature canities between 8 and 25 years of age only.[10] However, published evidence is lacking and needs to be generated in randomized placebo-controlled trials. Nowadays, there are a few industries which are used Melitane™ as an active ingredient including Lucas Meyer Cosmetics,[10] Alembic Pharmaceuticals,[11] and Redenhair.[12] Altris 5 solutions and Altris gel are two main Melitane™-containing products manufactured by Alembic Pharmaceuticals, India.[11] Anti-gray lotion, manufactured by Redenhair, the worldwide specialist in hair health, used Melitane™ as one of the active ingredients in the lotion, and they carried out three studies to evaluate the clinical effectiveness of Melitane™. The findings suggested that it decreases the number of poorly pigmented and nonpigmented cells and raises the amount of moderate and profoundly pigmented cells in the hair bulb, reversing the process of gray hair formation. Another study demonstrates the transfer properties of Melitane™, and the results revealed that it induces the formation of dendrites facilitating the transfer of melanosomes (melanin) in the skin. At the last study, it could be verified that Melitane™ stimulates pigmentation and melanin pigment, a natural protection factor under UV radiation.[12] Irritation and itching of the scalp are main side effects associated with it and contraindicated in case of hypersensitivity toward the drug Melitane™ or any other allergies.[10] It is not a Food and Drug Administration-approved drug. However, the treatment of Melitane and oral hair supplements is very costly; expecting nearly 2000 rupees/month, no other therapy is as effective. Due to its effectiveness in PHG and simple to utilize, it will become the favored alternative for the physician, for the patient who can afford its cost.
Our concern was to guide the clinician to deal with PHG, and patients get early treatment without compromising social life. As per our suggestion, certain investigations such as serum iron, copper, Vitamin B12, Vitamin D3, calcium, and thyroid profile may be conducted in individuals, with very early onset in the absence of any family history, and these findings will guide clinicians to choose an effective treatment option for PHG as it is associated with cause.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| » References | | |
| 1. | Fatemi Naieni F, Ebrahimi B, Vakilian HR, Shahmoradi Z. Serum iron, zinc, and copper concentration in premature graying of hair. Biol Trace Elem Res 2012;146:30-4.  |
| 2. | Choi JW, Lew BL, Sim WY. A case of premature hair graying treated with ferrous sulfate. Ann Dermatol 2016;28:775-6. |
| 3. | Bhat RM, Sharma R, Pinto AC, Dandekeri S, Martis J. Epidemiological and investigative study of premature graying of hair in higher secondary and pre-university school children. Int J Trichology 2013;5:17-21. |
| 4. | Sonthalia S, Priya A, Tobin DJ. Demographic characteristics and association of serum Vitamin B12, ferritin and thyroid function with premature canities in Indian patients from an urban skin clinic of North India: A retrospective analysis of 71 cases. Indian J Dermatol 2017;62:304-8. [Full text] |
| 5. | Goodier M, Hordinsky M. Normal and aging hair biology and structure 'aging and hair'. Curr Probl Dermatol 2015;47:1-9. |
| 6. | Han R, Beppu H, Lee YK, Georgopoulos K, Larue L, Li E, et al. Apair of transmembrane receptors essential for the retention and pigmentation of hair. Genesis 2012;50:783-800. |
| 7. | Schouwey K, Delmas V, Larue L, Zimber-Strobl U, Strobl LJ, Radtke F, et al. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn 2007;236:282-9. |
| 8. | Hachiya A, Sriwiriyanont P, Kobayashi T, Nagasawa A, Yoshida H, Ohuchi A, et al. Stem cell factor-KIT signalling plays a pivotal role in regulating pigmentation in mammalian hair. J Pathol 2009;218:30-9. |
| 9. | Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman's Pharmacological Basis of Therapeutics. 12 th ed. New York: McGraw-Hill; 2011. |
| 10. | |
| 11. | |
| 12. | |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
MC1R Peptide Agonist Self-Assembles into a Hydrogel That Promotes Skin Pigmentation for Treating Vitiligo |
|
| Ci Zhu, Tingting Li, Zhuole Wang, Zenghui Li, Jiaying Wei, Hong Han, Dan Yuan, Minying Cai, Junfeng Shi | | ACS Nano. 2023; | | [Pubmed] | [DOI] | | | 2 |
Development of novel frog-skin peptide scaffolds with selectivity towards melanocortin receptor subtypes |
|
| Uru Malik, Lai Yue Chan, Minying Cai, Victor J. Hruby, Quentin Kaas, Norelle L. Daly, David J. Craik | | Peptide Science. 2021; 113(4) | | [Pubmed] | [DOI] | | | 3 |
Premature graying of hair: A concise review |
|
| Rashmi Singh, Bhushan Madke, Shashank Bansod, Nidhi Yadav | | Cosmoderma. 2021; 1: 65 | | [Pubmed] | [DOI] | | | 4 |
Premature graying of hair: Risk factors, co-morbid conditions, pharmacotherapy and reversal—A systematic review and meta-analysis |
|
| Saniya Mahendiratta, Phulen Sarma, Hardeep Kaur, Sukhmandeep Kaur, Harpinder Kaur, Seema Bansal, Davinder Prasad, Manisha Prajapat, Sujata Upadhay, Subodh Kumar, Harish Kumar, Rahul Singh, Ashutosh Singh, Abhishek Mishra, Ajay Prakash, Bikash Medhi | | Dermatologic Therapy. 2020; 33(6) | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
